It's possible MNKD is finally self-correcting itself to true market value. We have an FDA approved, game changer, powder insulin that is really starting to catch on because it works miracles. IMO this stock has been severally undervalued for the longest time. Al Mann got this one right again. Sure wish he was still around to see all this unfold. Afrezza is going to be a thing of beauty for diabetics worldwide. Kudos also in order for Matt P, Michael C. Dr. Urbanski, MNKD sales team, and others for their hard work. Aloha.
News 
Market Data 
Discover 
AI
